Supernus Pharmaceuticals Inc (0LB2)
LSE
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 215M | 302.24M | 408.9M | 392.76M | 520.4M | 586.31M | 667.75M | 609.04M |
| Operating Income | 54.22M | 99.54M | 144.44M | 148.57M | 173.7M | 86.03M | 46.12M | -5.27M |
| Pre Tax Income | 50.37M | 100.62M | 140.18M | 147.49M | 168.65M | 73.18M | 60.74M | 2.77M |
| Net Income | 91.22M | 57.28M | 110.99M | 113.06M | 126.95M | 53.42M | 60.71M | 1.32M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 1.825 | 1.116 | 2.122 | 2.152 | 2.401 | 1.003 | 1.119 | 0.024 |
| EBIT | 53.53M | 99.25M | 144.44M | 148.57M | 173.7M | 86.03M | 46.12M | -5.27M |
| EBITDA | 56.62M | 107.64M | 151.54M | 155.23M | 193.7M | 118.62M | 131.67M | 99.78M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
